FIFTH EXTENSION - GRANTED
granted
on 24 Jun 2024
Last Applicant/ Owned by
2071 North Southport, Suite 201
Chicago
IL
60614
Serial Number
88893382 filed on 29th Apr 2020
Registration Number
N/A
Correspondent Address
Eric R. Moran
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
XENTRIA
research and development of biologics, biosimilars, and pharmaceuticals; providing information in the field of scientific and medical research related to biologics, biosimilars, and pharmaceuticals providing medical information; providing health information house mark for a full line of biologic, biosimilar, and pharmaceutical preparations; house mark for a full line of biologics; house mark for Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
providing medical information; providing health information
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
research and development of biologics, biosimilars, and pharmaceuticals; providing information in the field of scientific and medical research related to biologics, biosimilars, and pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
house mark for a full line of biologic, biosimilar, and pharmaceutical preparations; house mark for a full line of biologics; house mark for a full line of biosimilars; house mark for a full line of pharmaceuticals; house mark for a full line of biologic, biosimilar, and pharmaceutical products; biologic, biosimilar, and pharmaceutical preparations for the treatment of bone disease; biologic, biosimilar, and pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith; biologic, biosimilar, and pharmaceutical preparations for the treatment of diabetes; biologic, biosimilar, and pharmaceutical preparations for treatment and prevention of autoimmune diseases and autoimmune disorders; biologic, biosimilar, and pharmaceutical oncology preparations; anti-inflammatories; biologic, biosimilar, and pharmaceutical preparations for the treatment of immune system related diseases and disorders; biologic, biosimilar, and pharmaceutical preparations for use in dermatology; biologic, biosimilar, and pharmaceutical preparations for use in rheumatology; biologic, biosimilar, and pharmaceutical preparations, namely, anti-interleukin-6 (IL-6) receptor monoclonal antibody for the treatment of disease caused by IL-6 production; biologic, biosimilar, and pharmaceutical preparations, namely, biopharmaceuticals based on human monoclonal antibodies for the treatment of immune and inflammatory diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88893382
Mark Type
No Service Mark
Attorney Docket Number
No MBHB 20-729
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 24th Jun 2024 | SOU EXTENSION 5 GRANTED |
| 24th Jun 2024 | SOU EXTENSION 5 FILED |
| 24th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 24th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 16th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Dec 2023 | SOU EXTENSION 4 GRANTED |
| 14th Dec 2023 | SOU TEAS EXTENSION RECEIVED |
| 14th Dec 2023 | SOU EXTENSION 4 FILED |
| 22nd Jun 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 20th Jun 2023 | SOU EXTENSION 3 GRANTED |